Claris Ventures — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Lever Bioleverbio.com inMay 2025✓ verified

Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies.

BiotechDeep TechHealthtechMedical Devices

Pietro Puglisi(Chief Executive Officer)in

Co-investorsExor Ventures Italian Angels for Growth Club degli Investitori Ora Global

Haptenahaptena.com inDec 2025

Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors.

BiotechHealthtech

Chiara Ambrogio(Co-founder)Roberto Chiarle(Co-founder)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.